Apoptosis May Have a Role in Etiopathogenesis of Obstetric Cholestasis.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02192177|
Recruitment Status : Unknown
Verified July 2014 by Ali Ozgur Ersoy, Zekai Tahir Burak Women's Health Research and Education Hospital.
Recruitment status was: Recruiting
First Posted : July 16, 2014
Last Update Posted : July 16, 2014
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||50 participants|
|Observational Model:||Case Control|
|Official Title:||Apoptosis May Have a Role in Etiopathogenesis of Obstetric Cholestasis.|
|Study Start Date :||September 2013|
|Estimated Primary Completion Date :||August 2014|
|Estimated Study Completion Date :||August 2014|
Pregnant subjects diagnosed with obstetric cholestasis who didn't have any foreknown systemic disease.
entirely healthy pregnant subjects, the control group.
- M30 value as Unit per Liter. [ Time Frame: Four months. ]
- Percentage of delivery with cesarean section. [ Time Frame: Four months. ]
Biospecimen Retention: None Retained
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02192177
|Contact: Ali O Ersoyfirstname.lastname@example.org|
|Zekai Tahir Burak Maternity Teaching Hospital||Recruiting|
|Contact: Ali O Ersoy +905056579157 email@example.com|
|Principal Investigator: Ali O Ersoy|
|Principal Investigator:||Ali O Ersoy||Medical doctor|